BioSpace News Archive

Genetown

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Bardet-Biedl Syndrome

Rhythm Pharmaceuticals, Inc. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending to expand the current marketing authorization for IMCIVREE.

July 22, 2022
·
10 min read
Biotech Beach

Evofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act

Evofem Biosciences, Inc., (Nasdaq: EVFM), a women’s healthcare company, today applauded the 228 members of the U.S. House of Representatives who voted to pass legislation to safeguard access to contraceptives entitled The Right to Contraception Act.

July 22, 2022
·
2 min read
Biotech Beach

MDbio Starts Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Stress and Pain

Today, MDbio, in conjunction with their research partners at Radicle Science, are announcing the start of three separate clinical trial studies which will assess the efficacy of individual products that target sleeplessness, pain and stress.

July 22, 2022
·
3 min read
Business

Todos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary Supplementation

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the preprint in ResearchGate of case study #8 entitled “A Case Review.

July 22, 2022
·
7 min read
Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering

Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager in connection with this offering.

July 22, 2022
·
5 min read
Biotech Beach

Kite’s CAR T-cell Therapy Tecartus® Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)

Kite’s CAR T-cell Therapy Tecartus ® Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL).

July 22, 2022
·
14 min read
Business

Labcorp Earns Top Score on 2022 Disability Equality Index

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it scored 100, the highest score possible, on the 2022 Disability Equality Index® (DEI), a comprehensive benchmarking tool for measuring disability inclusion in the workplace.

July 22, 2022
·
4 min read
Policy

FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health

The U.S. Food and Drug Administration prioritizes the health and safety of American consumers and patients as well as animals and uses a variety of tools for the appropriate oversight of FDA-regulated products and establishments.

July 22, 2022
·
5 min read
Pharm Country

Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced Linear

Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production at the 2nd Annual mRNA-Based Therapeutics Summit.

July 22, 2022
·
5 min read
Business

Alimera Sciences to Report Second Quarter 2022 Financial Results on Wednesday, July 27, 2022, and Provide Corporate Update

Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), announces today that it will report second quarter financial results on Wednesday, July 27, 2022, before the market opens.

July 22, 2022
·
1 min read